Results 351 to 360 of about 351,966 (398)
Some of the next articles are maybe not open access.
CYTOGENETICS IN ADULT ACUTE LYMPHOCYTIC LEUKEMIA
Hematology/Oncology Clinics of North America, 2000The outcome of adult ALL patients has improved over the years, with an increase in median DFS from 0.9 years before 1988 to 1.7 years alter 1988. There is still ample room for improvement. Cytogenetic analysis at diagnosis can assist in developing risk-adapted therapeutic strategies and in devising new treatment modalities by an understanding of the ...
openaire +2 more sources
Total Therapy of Acute Lymphocytic Leukemia
JAMA: The Journal of the American Medical Association, 1972In 1962, the total therapy approach to acute lymphocytic leukemia was developed at St. Jude Children's Research Hospital. Briefly, it consists of rapid and efficient induction of complete remission with prednisone and vincristine in order to minimize early attrition, cranial or craniospinal irradiation during the first month of complete remission to ...
openaire +2 more sources
Philadelphia Chromosome–Positive Acute Lymphocytic Leukemia
Hematology/Oncology Clinics of North America, 2001On a molecular and cellular level, Ph+ ALL seems to be a heterogeneous disease. Unfortunately, the unifying theme of Ph positivity is the poor outcome associated with its presence. Further characterization of molecular subtypes of Ph+ ALL may in the future distinguish those few patients with a potentially good outcome from the majority who face ...
openaire +2 more sources
Childhood acute lymphocytic leukemia.
Comprehensive therapy, 1976Childhood ALL is a potentially curable disease. All children suffering from this ailment should be given an opportunity to live by receiving therapy aimed at permanent cure. The disease requires extensive, complex, and costly diagnostic study and treatment.
openaire +1 more source
New Therapeutic Strategies in Acute Lymphocytic Leukemia
Current Hematologic Malignancy Reports, 2017L. Man, A. Morris, M. Keng
semanticscholar +1 more source
Pediatric Acute Lymphocytic Leukemia
DHR Proceedings, 2022Paris Canales +9 more
openaire +1 more source
CAR T Cell Therapy in Acute Lymphoblastic Leukemia and Potential for Chronic Lymphocytic Leukemia
Current Treatment Options in Oncology, 2016Nathan Singh +3 more
semanticscholar +1 more source
Critical care management of chimeric antigen receptor T‐cell therapy recipients
Ca-A Cancer Journal for Clinicians, 2022Alexander Shimabukuro-Vornhagen +2 more
exaly